Doximity, which ranks fifth on the IBD 50, crushed December-quarter expectations late Thursday and raised its outlook for the ...
Well, McDonald’s is resurfacing another popular vintage character this month—one who hasn’t been around since the ’80s. Can ...
The drugmaker Bristol Myers Squibb has been a standout among its big pharma peers over the past six months, scoring a ...